by Sarah Moniz | Jun 11, 2018 | Featured, News
PROVIDENCE, R.I., June 11, 2018 — EpiVax announces their move to a new headquarters at 188 Valley Street, in the “Rising Sun” complex, a former wool mill in the Olneyville section of Providence, Rhode Island. The privately held bioinformatics company is also...
by Sarah Moniz | May 18, 2018 | Featured, News
PROVIDENCE, R.I., May 18, 2018 /PRNewswire/ — The National Institutes of Health (NIH) has awarded EpiVax, Inc. (“EpiVax”), experts in the field of immunogenicity risk assessment, a $324,980 Small Business Innovation Research (SBIR) grant. The funding will enable...
by Sarah Moniz | Mar 8, 2018 | Featured, News, Thinking Out Loud -Blog
PROVIDENCE, R.I., March 9, 2018 /PRNewswire/ — EpiVax Inc., (“EpiVax”) an innovative Rhode Island-based biotechnology company, has a lot to celebrate on International Women’s Day. The company, founded and led by Dr. Annie De Groot, boasts a...
by Sarah Moniz | Jan 26, 2018 | Thinking Out Loud -Blog
The CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated nuclease-9) system has been a model of great promise in the gene therapy research community since 2012. It was initially discovered as the adaptive immune system of certain...
by Sarah Moniz | Dec 19, 2017 | News, Thinking Out Loud -Blog
It all started in 2008, when Drs. Leslie and Annie De Groot, father and daughter, applied for a joint SBIR. Using their combined knowledge, as world leading endocrinologist and immunologist, they set out to develop a new way to treat Graves’ disease, an...
